<DOC>
	<DOCNO>NCT02421380</DOCNO>
	<brief_summary>The purpose study test new approach see test result reproduce time Magnetic resonance imaging ( MRI ) do individual patient . The study explore use image agent call hyperpolarized [ 1-13C ] pyruvate ( HP ) MRI scan . ( MRI ) technique take picture body 's organ use magnetic field radiofrequency wave felt . In order accomplish goal study patient two hyperpolarized MRI scan assess scan reproduce . The hyperpolarized MRI scan compare pathological result surgery see hyperpolarized MRI provide additional information regard disease metabolism .</brief_summary>
	<brief_title>Characterization Hyperpolarized Pyruvate MRI Reproducibility</brief_title>
	<detailed_description />
	<criteria>Patients history histologicallyconfirmed malignant solid tumor ( histology confirm MSKCC Department Pathology . ) NOTE : An exception make patient brain lesion . Patients identified radiologist brain lesion high suspicion neoplasm give MRI feature enrol , prior histological confirmation . Disease measurable evaluable define RECIST 1.1 , mass great 1cm long axis and/or tumor response criterion MSKCC IRBapproved clinical research protocol . NOTE : Study patient need participate MSKCC approve clinical trial prior study recruitment . Negative serum pregnancy test female patient childbearing age potential ( define MSKCC Standards &amp; Guidelines ) , assay obtain &lt; 2 week prior study enrollment . This study include patient sarcoma , prostate , breast , brain metastatic cancer . In future patient group may include amendment protocol . Inability refusal least one peripheral intravenous line intravenous access ( applicable day [ 113C ] pyruvate injection ) Breastfeeding Refusal inability tolerate scanning procedure ( e.g. , due claustrophobia ) Hepatic : assay obtain &lt; 2 week prior study enrollment . For patient , upper limit normal ( ULN ) value particular assay define normal reference value laboratory perform assay Bilirubin &gt; 1.5 x ( ULN ) AST/ALT &gt; 2.5 x ULN Albumin &lt; 3 g/dl GGT &gt; 2.5 x ULN Alkaline phosphatase &gt; 2.5 x ULN . Renal : Creatinine &gt; 1.5 x ULN creatinine clearance &lt; 60 mL/min , assay obtain &lt; 2 week prior study enrollment Acute major illness ( e.g. , unstable cardiovascular condition , etc . ) Standard MRI exclusion criterion also apply , include pacemaker metal clip locate patient .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Hyperpolarized Pyruvate</keyword>
	<keyword>MRI</keyword>
	<keyword>14-205</keyword>
</DOC>